Skip to main content
Egyptian Liver Journal

Table 6 Anemia (Hb < 10 g/dl) managements

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

Anemia

Management done

N

%

ESA (added or increased dose)

26

52.00

Blood transfusion

7

14.00

Ribavirin stopped

3

6.00

Ribavirin reduced

1

2.00

  1. ESA erythropoiesis-stimulating agents
Back to article page